Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
Product Unit Size | Cost | Quantity | Stock |
---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
Purity | ≥98% |
---|---|
Formula | C33H59N11O10 |
Formula Wt. | 769.90 |
Solubility | Soluble in water (2 mg/mL), acetonitrile. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Toxin produced by Aspergillus.
Imidazothiazole; alkaline phosphatase inhibitor...
Aromatic 1,3-diketone acetylacetone derivative ...
Fluoroquinolone; topoisomerase IV and bacterial...
Read-through agent and nonsense mutation target...
BRG1/BRM ATPase inhibitor
KRAS inhibitor
Antiviral againt SARS-CoV-2
Peptide, cleavage product of proenkephalin; κO...
Vitamin D, calcitriol prodrug; VDR agonist.
Neurotoxin frequently used to aid in modeling P...
Endogenous steroid hormone involved in reproduc...
Lincosamide; peptidyl transferase inhibitor, pr...
Thalidomide derivative; cereblon and TNF-α inh...
RIP1 inhibitor.
Hec1/Nek2 mitotic pathway inhibitor
DOT1L HMT inhibitor.
Tetracycline; protein translation inhibitor, MM...
Non-depolarizing NMJ blocker; nAChR and M2/3 mA...
Nucleoside (guanosine) analog; RT, guanylyl cyc...